Recently Dr Carmen Martínez Fernández was incorporated as a postdoc into the Dr Griñan-Ferré group on Neuroepigenetics and Drug Discovery. Dr Martínez-Fernández will be in charge of Behavioural phenotypes evaluation (locomotion, mechano- and chemosensation) and Gene editing by CRISPR/Cas by using as experimental model C. elegans. She will participate in several projects lead By Dr Griñán-Ferré related with drug development.
Lavilla’s group present Cutting-Edge MCR research at international conference in Olomou
Last week, Prof. Rodolfo Lavilla and Dr. Ouldouz Ghashghaei attended the 1st International Conference of Innovative Chemistry and Chemical Biology…
October 7, 2025
